Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care

Macquart-Moulin, G; Viens, Patrice; Bouscary, Marie-Laure; Genre, Dominique; Resbeut, M.; Gravis, Gwénaëlle; Camerlo, Jacques; Maraninchi, D; Moatti, Jean‐Paul

doi:10.1038/bjc.1997.610

Cited by 80 publications

(53 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Further descriptive questions will address interactions of factors such as CAM use, vitamin supplement use, quality of life, and prescription medication use. We will not be able to address immediately the association between lifestyle factors and traditional breast cancer outcomes of recurrence and death since the accumulation of a sufficient number of outcomes in the cohort will take several years, but we will have the ability to examine markers of treatment toxicities as outcomes, which is an emerging research priority in breast cancer prognosis [39][40][41]. For example, we would like to explore the impact of CAM use and weight change on chemotherapy toxicities, as well as genetic variants in DNA repair and oxidative stress pathways on chemotherapy toxicities.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California

Kwan

Ambrosone

Lee

et al. 2008

Cancer Causes Control

104

View full text Add to dashboard Cite

Objective-With 2.3 million breast cancer survivors in the U.S. today, identification of modifiable factors associated with breast cancer recurrence and survival is increasingly important. Only recently new studies have been designed to examine the impact of lifestyle factors on prognosis, including Pathways, a prospective study of women with breast cancer in Kaiser Permanente Northern California (KPNC).Methods-Pathways aims to examine the effect on recurrence and survival of 1) lifestyle factors such as diet, physical activity, quality of life, and use of alternative therapies and 2) molecular factors such as genetic polymorphisms involved in metabolism of chemotherapeutic agents. Eligibility includes any woman diagnosed with invasive breast cancer within KPNC, no previous diagnosis of other invasive cancer, age 21 years or older, and ability to speak English, Spanish, Cantonese, or Mandarin. Newly-diagnosed patients are identified daily from electronic pathology records and are enrolled within two months of diagnosis. An extensive baseline interview is conducted, blood and saliva samples are collected, and body measurements are taken. Women are followed for lifestyle updates, treatment, and outcomes by self-report and query of KPNC databases.Results-Recruitment began in January 9, 2006, and as of January 16, 2008, 1,539 women have been enrolled along with collection of 1,323 blood samples (86%) and 1,398 saliva samples (91%). Conclusions-ThePathways Study will become a rich resource to examine behavioral and molecular factors and breast cancer prognosis.

show abstract

Section: Discussionmentioning

confidence: 99%

“…No 76 (22) 98 (21) 103 (24) 74 (25) 351 (23) 570 ( 236 (72) 165 (74) 808 (68) 1,237 (65) Regional 105 (40) 113 (31) 82 (25) 56 (25) 356 (30) 590 ( 8 (2) 8 (3) 3 (1) 22 (2) 72 ( 189 (51) 181 (55) 122 (55) 595 (50) 899 (47) II 103 (39) 121 (33) 97 (30) 63 (28) 384 (32) 637 (33) III 43 (16) 37 (10) 26 (8) 20 (9) 126 (11) 186 (10) IV 3 (1)…”

Section: <0001unclassified

The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California

Kwan

Ambrosone

Lee

et al. 2008

Cancer Causes Control

104

View full text Add to dashboard Cite

show abstract

“…Previous studies had already shown that there may be some disparity between the physician's estimations and a patient's selfassessment of treatment side-effects and experience. 12 Some limitations of our study must be acknowledged. In the group of donors who experienced BM harvest, the last measurement of pain occurred soon after recovery from anaesthesia, and it would have been interesting to repeat such a measurement a few days later in order to assess how long it persisted after surgery, and then to have an idea not only on the intensity, but also on duration of this pain.…”

Section: Discussionmentioning

confidence: 99%

Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised study

Fortanier

Kuentz²,

Sutton

et al. 2002

Bone Marrow Transplant

Self Cite

View full text Add to dashboard Cite

Summary:This study reports the first comparison of healthy donor subjective well-being during two alternative procedures of hematopoietic stem cells harvesting for allogeneic transplantation. Among the 105 donors included between September 1996 and October 1998 in the SFGM French randomised trial aiming to compare allogeneic bone marrow (BM) transplantation and blood cell (BC) transplantation, 64 donors (33 in BC and 31 in BM groups) were relevant for the analysis. They had received a set of self-administered questionnaires to complete during the collection process, aiming to measure anxiety (assessed using the Spielberger's State-Trait Anxiety Inventory) and pain induced by the procedure (evaluated using a visual analogical scale). Results showed that no harvest procedure is free from pain even if none was more painful than the other. Levels of anxiety before the collection procedure were high in both groups and significantly so for BC donors. Although BC collection induces at least similar levels of pain and anxiety as does BM collection, they were of a different kind, and the short-term impact of G-CSF stimulation on the well-being of BC donors has to be taken into account in improving quality of care in the allogeneic setting. Bone Marrow Transplantation (2002) 29, 145-149. DOI: 10.1038/sj/bmt/1703338 Keywords: healthy donors; hematopoietic stem cell harvest; anxiety; pain; allogeneic transplantation Blood cell transplantation (BCT) is now the standard for autologous transplant: 1 the main arguments in favour of substituting this procedure for classical bone marrow transplantation (BMT) in the autologous setting were quicker haematological recovery, decrease in related cost 2,3 and easier progenitor collection associated with an increased

show abstract

“…For example, in a randomized trial comparing two dose-intensive chemotherapy regimens among 363 women with breast cancer, general psychological distress was potentially associated with the degree of alopecia, although the significant association became non-significant in multivariate analysis that adjusted for other toxicities and the two different chemotherapy regimens [31]. Distress associated with hair loss seems to increase with the number of chemotherapy received [23].…”

Section: Relative Importance Of Hair Loss Among Chemotherapy-related mentioning

confidence: 99%

Chemotherapy‐induced alopecia and effects on quality of life among women with breast cancer: a literature review

2007

View full text Add to dashboard Cite

Background: Alopecia is a common side effect of chemotherapies used in the treatment of breast cancer. The aim of this review is to describe the effects of alopecia on quality of life (QOL) in this population.Methods: We conducted a literature review using Medline, Embase, Cumulative Index to Nursing and Allied Health Literature and PsycInfo databases. We searched for studies on the effects of alopecia on various aspects of QOL in breast cancer patients including anxiety and distress, body image, sexuality, self‐esteem, social functioning, global QOL and return to work outcomes.Results: A total of 38 articles were included in the review. Hair loss consistently ranked amongst the most troublesome side effects, was described as distressing, and may affect the body image.Conclusions: We found very little quantitative data on other aspects of QOL. More research is needed to determine the presence and extent of negative effects on chemotherapy‐induced alopecia on various aspects of QOL. Copyright © 2007 John Wiley & Sons, Ltd.

show abstract

Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care

Cited by 80 publications

References 33 publications

The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California

The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California

Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised study

Chemotherapy‐induced alopecia and effects on quality of life among women with breast cancer: a literature review

Contact Info

Product

Resources

About